Boomerang Therapeutics

Personalized Cancer Gene Therapy

Health Tech & Life Sciences
Non Active, Jan 2017
Pre-Funding Be'er Sheva, Israel Founded 2015
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2015
Headcount
6
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

Boomerang Therapeutics develops a genetic device for cancer therapy. Using advanced gene editing tools, thesystem is able to effectively eliminate cancer cells by activating suicide genes. Thesystem can be potentially designed according to the genetics of each patient's tumor, paving the way to personalized treatment.

Q&A

What is Boomerang Therapeutics' primary focus?
Boomerang Therapeutics focuses on personalized cancer gene therapy, developing a genetic device that uses advanced gene editing tools to eliminate cancer cells by activating suicide genes.
When was Boomerang Therapeutics founded?
Boomerang Therapeutics was founded in March 2015.
What is the current status of Boomerang Therapeutics?
Boomerang Therapeutics is currently inactive, a status it has held since January 2017.
Where is Boomerang Therapeutics headquartered?
Boomerang Therapeutics is headquartered in Be'er Sheva, South District, Israel.
How many employees does Boomerang Therapeutics have?
Boomerang Therapeutics has 1-10 employees.
Who are the founders of Boomerang Therapeutics?
The founders of Boomerang Therapeutics are Ori Zelichov, who serves as Founder & CEO, and Shai Duchin, who is a Co-Founder.
In which sector does Boomerang Therapeutics operate?
Boomerang Therapeutics operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Does Boomerang Therapeutics hold any patents?
Yes, Boomerang Therapeutics holds 1 patent.

Team · 2

Founder · Founder & CEO
LinkedIn ↗
Founder · Co-Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

genetic-engineeringmolecular-biologygenomicspersonalized-medicine
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2015-3
Employees (exact)6
Status reasonNon Active, Jan 2017